EP1303281A4 - Methods of treatment - Google Patents

Methods of treatment

Info

Publication number: EP1303281A4
Authority: EP; European Patent Office
Prior art keywords: treatment; methods
Prior art date: 2000-04-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP01927076A

Other languages

German (de)

French (fr)

Other versions

EP1303281A1 (en

Inventor

Maxwell D Cummings

Robert W Marquis Jr

Yu Ru

Scott K Thompson

Daniel F Veber

Dennis S Yamashita

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-18

Filing date

2001-04-17

Publication date

2006-02-15

2001-04-17 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2003-04-23 Publication of EP1303281A1 publication Critical patent/EP1303281A1/en

2006-02-15 Publication of EP1303281A4 publication Critical patent/EP1303281A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

EP01927076A 2000-04-18 2001-04-17 Methods of treatment Withdrawn EP1303281A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US19771700P	2000-04-18	2000-04-18
US197717P		2000-04-18
PCT/US2001/012386 WO2001078734A1 (en)	2000-04-18	2001-04-17	Methods of treatment

Publications (2)

Publication Number	Publication Date
EP1303281A1 EP1303281A1 (en)	2003-04-23
EP1303281A4 true EP1303281A4 (en)	2006-02-15

Family

ID=22730469

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP01927076A Withdrawn EP1303281A4 (en)	2000-04-18	2001-04-17	Methods of treatment

Country Status (5)

Country	Link
EP (1)	EP1303281A4 (en)
JP (1)	JP2003531122A (en)
AU (1)	AU2001253560A1 (en)
CO (1)	CO5280093A1 (en)
WO (1)	WO2001078734A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002342682A1 (en) *	2001-05-17	2002-11-25	Smithkline Beecham Corporation	Protease inhibitors
US20060166966A1 (en) *	2002-10-08	2006-07-27	Cameron Black	4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis
EP2719700A1 (en)	2008-01-09	2014-04-16	Amura Therapeutics Limited	Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases

Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001034154A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034156A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034160A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034155A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034565A2 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034158A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034566A2 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001070232A1 (en) *	2000-03-21	2001-09-27	Smithkline Beecham Corporation	Protease inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1253441C (en) *	1998-12-23	2006-04-26	史密丝克莱恩比彻姆公司	Protease inhibitors

2001
- 2001-04-16 CO CO01029288A patent/CO5280093A1/en not_active Application Discontinuation
- 2001-04-17 JP JP2001576034A patent/JP2003531122A/en not_active Withdrawn
- 2001-04-17 AU AU2001253560A patent/AU2001253560A1/en not_active Abandoned
- 2001-04-17 EP EP01927076A patent/EP1303281A4/en not_active Withdrawn
- 2001-04-17 WO PCT/US2001/012386 patent/WO2001078734A1/en not_active Ceased

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001034154A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034156A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034160A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034155A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034565A2 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034158A1 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001034566A2 (en) *	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
WO2001070232A1 (en) *	2000-03-21	2001-09-27	Smithkline Beecham Corporation	Protease inhibitors

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHAPMAN HAROLD A JR ET AL: "The role of thiol proteases in tissue injury and remodeling", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 150, no. 6 PART 2, 1994, pages S155 - S159, XP009059181, ISSN: 1073-449X *
NAKAGAWA TERRY ET AL: "Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus", SCIENCE (WASHINGTON D C), vol. 280, no. 5362, 17 April 1998 (1998-04-17), pages 450 - 453, XP002360104, ISSN: 0036-8075 *
See also references of WO0178734A1 *

Also Published As

Publication number	Publication date
WO2001078734A1 (en)	2001-10-25
CO5280093A1 (en)	2003-05-30
JP2003531122A (en)	2003-10-21
AU2001253560A1 (en)	2001-10-30
EP1303281A1 (en)	2003-04-23

Publication	Publication Date	Title
GB0014969D0 (en)	2000-08-09	Novel method of treatment
GB2393202B (en)	2005-12-21	Methods of well treatment
IL213240A0 (en)	2011-07-31	Method of treatment using lighnd-immunogen conjugates
GB0028264D0 (en)	2001-01-03	Well treatment
GB0007193D0 (en)	2000-05-17	Treatment of movrmrnt disorders
GB0028269D0 (en)	2001-01-03	Well treatment
AU5464601A (en)	2001-09-12	Treatment of scale
PL362855A1 (en)	2004-11-02	Improved treatment
EG25829A (en)	2012-09-02	Novel treatment
AU5000001A (en)	2001-09-03	Treatment of vitiligo
GB0124124D0 (en)	2001-11-28	Methods of treatment
GB0112216D0 (en)	2001-07-11	Method of treatment
GB2360453B (en)	2004-09-01	Treatment of skin conditions
AU9402401A (en)	2002-04-22	Treatment of cancers
GB0008921D0 (en)	2000-05-31	Method of treatment
GB0026838D0 (en)	2000-12-20	Treatment method
GB0118892D0 (en)	2001-09-26	Method of treatment
GB0130763D0 (en)	2002-02-06	Treatment methods
IL161630A0 (en)	2004-09-27	Methods of treating endometreosis
EP1303281A4 (en)	2006-02-15	Methods of treatment
GB0031321D0 (en)	2001-02-07	Treatment
GB0014904D0 (en)	2000-08-09	Methods of treatment
GB0013928D0 (en)	2000-08-02	Methods of treatment
GB0002762D0 (en)	2000-03-29	Method of treatment
GB0026742D0 (en)	2000-12-20	Novel method of treatment

Legal Events

Date	Code	Title	Description
2003-03-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2003-04-23	17P	Request for examination filed	Effective date: 20021118
2003-04-23	AK	Designated contracting states	Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2003-04-23	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2006-02-08	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 11/06 20060101ALI20051221BHEP Ipc: A61P 35/04 20060101ALI20051221BHEP Ipc: A61P 35/00 20060101ALI20051221BHEP Ipc: A61K 31/44 20060101ALI20051221BHEP Ipc: A61K 31/55 20060101AFI20011101BHEP
2006-02-15	A4	Supplementary search report drawn up and despatched	Effective date: 20060104
2009-11-27	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1056502 Country of ref document: HK
2011-05-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2011-06-15	18D	Application deemed to be withdrawn	Effective date: 20060617